 - To determine if polymorphisms in genes e.g., CYBA, RAC2, NCF4, MRP1, MRP2, GTSP and CBR3 in women with breast cancer treated with doxorubicin hydrochloride increase the relative risk of developing NCI grade 1 cardiotoxicity. Primary study 